The tyrosine kinase receptor c-Met plays a key role in cell proliferation, morphogenesis, and motility in response to hepatocyte growth factor. C-Met is often altered in cancer and is a major target for therapeutic intervention. Despite knowing a great deal of the molecular machinery downstream of this receptor tyrosine kinase, the spatiotemporal regulation of c-Met signaling still remains elusive. In this issue of the Journal of Cell Biology, Kermorgant and Parker (Kermorgant, S. and P.J. Parker. 2008. J. Cell Biol. 182:855 -863) provide evidence for a model in which the c-Met -activated STAT3 signal is mediated by endosomal traffi cking. This study elegantly highlights how weak signals can be effectively transmitted to the nucleus by exploiting endosomal compartments, raising important mechanistic implications for the signaling research community.
Correspondence to Marino Zerial: zerial@mpi-cbg.de STAT3 signaling came from experiments showing that EGF stimulation of cells resulted in STAT3 localization to endosomes and endocytosis was important for STAT3-dependent transcription ( Bild et al., 2002 ) . Endocytosis was later demonstrated to be involved in some HGF-mediated signaling events ( Hammond et al., 2003 ; Kermorgant et al., 2003 Kermorgant et al., , 2004 including HGF-induced Rac traffi cking in cell migration ( Palamidessi et al., 2008 ) . The questions of why c-Met -dependent STAT3 activation should require transport to endosomes instead of free diffusion through the cytoplasm and of how universal this mode of STAT3 signaling is remain a mystery.
In this issue of the Journal of Cell Biology, Kermorgant and Parker (see p. 855) provide a possible answer to these questions by demonstrating an unexpected relationship between the strength of the signaling response (e.g., activation by phosphorylation) and the traffi cking of the receptor and downstream signaling components. The authors compared the activation of ERK1/2 and STAT3 with the intracellular traffi cking of c-Met in response to HGF stimulation. The authors found that HGF elicits a potent activation of ERK1/2 that requires internalization of c-Met into endosomes but does not require its traffi cking to a perinuclear compartment (Fig. 1) . In contrast, STAT3 activation is comparatively " weak " and requires the localization of active c-Met to the perinuclear region via a microtubule and PKC ␣ -dependent process (Fig. 1) . Interestingly, STAT3 activation via the cytokine Oncostatin M produces a " stronger " signal that occurs independently of microtubules and PKC ␣ (Fig. 1 ). This result demonstrates that the traffi cking of STAT3 to endosomes is not an absolute requirement for activity but rather depends on the " signal strength " elicited by the growth factorreceptor complex. The involvement of the endocytic pathway in STAT3 signaling was also recently shown for IL-6 and, if it follows the trend established here, then one would predict the IL-6 -mediated STAT3 signal also to be weak ( Shah et al., 2006 ) .
The fi ndings presented in this study pose several interesting problems for the entire fi eld of receptor-mediated signaling and membrane traffi cking. Increasing evidence has been accumulating in favor of the " signaling endosome " hypothesis, whereby signals are sustained or generated on endosomes and compartmentalization is exploited to generate quantitative and qualitative Another question is which type of endosomal compartment is involved in c-Met -dependent STAT3 signaling? The identity of the perinuclear endosomal compartments accessed by c-Met over time has not yet been well characterized. Signaling could be elicited from recycling endosomes or late endocytic compartments, both of which are positioned mainly in the perinuclear region of the cell. This question is important in view of recent data implicating a newly identifi ed endosomal compartment (APPL-positive endosomes) with an unexpected role in signal specifi city ( Miaczynska et al., 2004 ; Schenck et al., 2008 ) . As shown for several receptors Mao et al., 2006 ; Erdmann et al., 2007 ) , c-Met (at least a fraction of receptor) could also enter and signal from APPL endosomes. It would be informative to determine if there is also a STAT3 APPL-positive endosomal population and, if so, whether there is a functional specifi city to this endosomal STAT3 signal.
Interestingly, the transport of transcription factors via endosomes to a perinuclear location and the concomitant evidence of endosomal proteins found in the nucleus suggest that there is a widespread role for endocytic proteins in transcriptional regulation ( Pilecka et al., 2007 ) . The authors of the present study did not address the transcriptional activity of STAT3 but, instead, equated nuclear presence to transcriptional activity. Are there, in fact, functional differences between the transcriptional profi les of soluble cytosolic STAT3 versus STAT3 activated on endosomes? STAT3 has recently been shown to have an additional role in the cytoplasm. It can bind to the microtubule binding protein stathmin and antagonize its microtubule destabilizing activity leading to a reorganization of the microtubule network ( Ng et al., 2006 ) . Clearly, we need to explore further the role of signaling molecules as traffi cking regulators, as signal transduction is known to modulate membrane and cytoskeleton dynamics.
The functional outcome of c-Met activation is a fi ne balance between signaling pathways using diffusion and those requiring endosomal traffi cking. As presented in this issue, HGF binding to c-Met results in the compartmentalization of activated STAT3 to endosomes thus allowing a weak signal to reach the nucleus. These studies have been conducted in HeLa cells as a model system. Next, it will be important to validate the conclusions of this study in model organisms, where mechanistic differences can be highlighted under physiological conditions. differences in signals. Some of the fundamental questions follow. Which objective criteria defi ne signal strength? In the current study, only a systematic quantitative functional analysis coupled to mathematical modeling can provide a precise assessment of signal strength for each signaling system. Furthermore, which molecular features of the signaling machinery determine the signal strength and to what extent are endosomal compartments involved in this regulation? Signal strength can vary in a signaling cascade and quantitative differences may be exploited to generate different outcomes ( Santos et al., 2007 ) . The current study raises the question of why STAT3 traffi cs via endosomes. STAT3 may need to dynamically associate with activated c-Met, as suggested by Kermorgant and Parker (see p. 855) , perhaps engaging with endosomal signaling complexes yet to be identifi ed (as in the case of the p14 -MP1 -MAPK complex on late endosomes ( Wunderlich et al., 2001 ). There may be a conformational change that occurs upon binding to either the c-Met receptor in an endosomal compartment or other endosomal proteins. Another potential explanation is that the weak STAT3 signal may " survive " on endosomes where it may be protected from premature inactivation by the highly enriched cytoplasmic milieu of phosphatases ( Birtwistle et al., 2007 ) . Figure 1 . Survival of the weakest. Both ERK1/2 and STAT3 signaling require the endocytosis of the HGF-bound c-Met receptor. The signal strength differs between these two signaling proteins and this leads to disparate pathways to the nucleus. The strong ERK1/2 signal proceeds via cytosolic diffusion, whereas the weaker STAT3 signal requires a microtubuledependent perinuclear localization of c-Met. In comparison, a strong STAT3 signal mediated by Oncostatin M proceeds similarly to ERK1/2. OSMR, Oncostatin M receptor.
